Corcept Begins Trial of Relacorilant Combo in Resistant Ovarian Cancer Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage biopharmaceutical company focused on the discovery and development of innovative therapies that modulate…
Kashiv BioSciences Obtains $150 Million in Debt Financing from GoldenTree Asset Management Kashiv BioSciences, LLC (“Kashiv” or “the Company”), a fully integrated and innovation-driven biopharmaceutical company, announced today the successful…
Verge Genomics Identifies Digital Biomarkers for Early ALS Progression in VRG50635 Trial Verge Genomics, a trailblazer in AI-powered drug discovery and development, today announced pivotal findings that could reshape the…
Flatiron Health Partners with Massive Bio to Strengthen Patient Identification and Services In a strategic move poised to reshape the landscape of oncology clinical research, Flatiron Health, a leading health…
Hello Heart Launches Smart Pill Box to Transform Medication Adherence In a significant step forward for digital heart health management, Hello Heart, the leading digital platform for preventive heart care,…
EU Approves Expanded Use of KAFTRIO for Cystic Fibrosis Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) has announced a significant milestone in the ongoing fight against cystic fibrosis (CF). The European Commission…
Prollenium Announces Leadership Transition Prollenium Medical Technologies (“Prollenium” or “the Company”), a leading innovator in the aesthetic medical space, has announced a significant leadership change as Ario Khoshbin, its Founder…
Sentynl Unveils First Full Clinical Data Supporting NULIBRY® for MoCD Type A Sentynl Therapeutics, Inc. (“Sentynl”), a U.S.-based biopharmaceutical company and a wholly owned subsidiary of Zydus Lifesciences Ltd. (“Zydus…
Prollenium Unveils New Leadership Structure In a significant leadership transition aimed at fostering continued growth and innovation, Prollenium Medical Technologies (“Prollenium” or “the Company”) has announced that Ario Khoshbin, the…
RenovoRx to Present at LD Micro Invitational XV Conference in New York on April 10th RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company focused on the…
Hologic Appoints Wayde McMillan to Board of Directors Hologic, Inc. (Nasdaq: HOLX), an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment,…
Bayer Announces Petition Filing to U.S. Supreme Court for Review in Durnell Roundup Case On April 4, 2025, Bayer AG, through its indirect subsidiary Monsanto, officially filed a petition for…